New Acaster Lloyd Consulting publication on capturing cognitive decline in economic evaluations in MS

Our director Andrew Lloyd recently wrote a commentary entitled “Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued?” in Neurology. The full text is available here.